These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20657792)

  • 1. Erythropoietin Receptor Signaling Through STAT3 Is Required For Glioma Stem Cell Maintenance.
    Cao Y; Lathia JD; Eyler CE; Wu Q; Li Z; Wang H; McLendon RE; Hjelmeland AB; Rich JN
    Genes Cancer; 2010 Jan; 1(1):50-61. PubMed ID: 20657792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting A20 decreases glioma stem cell survival and tumor growth.
    Hjelmeland AB; Wu Q; Wickman S; Eyler C; Heddleston J; Shi Q; Lathia JD; Macswords J; Lee J; McLendon RE; Rich JN
    PLoS Biol; 2010 Feb; 8(2):e1000319. PubMed ID: 20186265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth.
    Wang H; Lathia JD; Wu Q; Wang J; Li Z; Heddleston JM; Eyler CE; Elderbroom J; Gallagher J; Schuschu J; MacSwords J; Cao Y; McLendon RE; Wang XF; Hjelmeland AB; Rich JN
    Stem Cells; 2009 Oct; 27(10):2393-404. PubMed ID: 19658188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells.
    Shi Y; Zhou W; Cheng L; Chen C; Huang Z; Fang X; Wu Q; He Z; Xu S; Lathia JD; Ping Y; Rich JN; Bian XW; Bao S
    Cell Death Differ; 2017 Jan; 24(1):167-180. PubMed ID: 27740621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA interference-mediated inhibition of erythropoietin receptor expression suppresses tumor growth and invasiveness in A2780 human ovarian carcinoma cells.
    Paragh G; Kumar SM; Rakosy Z; Choi SC; Xu X; Acs G
    Am J Pathol; 2009 Apr; 174(4):1504-14. PubMed ID: 19264915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine signals through STAT3 promote expression of granulocyte secondary granule proteins in 32D cells.
    Wang L; Arcasoy MO; Watowich SS; Forget BG
    Exp Hematol; 2005 Mar; 33(3):308-17. PubMed ID: 15730854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EPO-independent functional EPO receptor in breast cancer enhances estrogen receptor activity and promotes cell proliferation.
    Reinbothe S; Larsson AM; Vaapil M; Wigerup C; Sun J; Jögi A; Neumann D; Rönnstrand L; Påhlman S
    Biochem Biophys Res Commun; 2014 Feb; 445(1):163-9. PubMed ID: 24502950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT3 and hypoxia induced proteins--HIF-1alpha, EPO and EPOR in relation with Bax and Bcl-xL in nodal metastases of ductal breast cancers.
    Wincewicz A; Koda M; Sulkowska M; Kanczuga-Koda L; Wincewicz D; Sulkowski S
    Folia Histochem Cytobiol; 2009 Jan; 47(3):425-30. PubMed ID: 20164027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Erythropoietin in Cerebral Glioma: An Innovative Target in Neuro-Oncology.
    Torregrossa F; Aguennouz M; La Torre D; Sfacteria A; Grasso G
    World Neurosurg; 2019 Nov; 131():346-355. PubMed ID: 31658577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine 425 within the activated erythropoietin receptor binds Syp, reduces the erythropoietin required for Syp tyrosine phosphorylation, and promotes mitogenesis.
    Tauchi T; Damen JE; Toyama K; Feng GS; Broxmeyer HE; Krystal G
    Blood; 1996 Jun; 87(11):4495-501. PubMed ID: 8639815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local blockage of self-sustainable erythropoietin signaling suppresses tumor progression in non-small cell lung cancer.
    He L; Wu S; Hao Q; Dioum EM; Zhang K; Zhang C; Li W; Zhang W; Zhang Y; Zhou J; Pang Z; Zhao L; Ma X; Li M; Zhang Q
    Oncotarget; 2017 Oct; 8(47):82352-82365. PubMed ID: 29137269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin ameliorates early brain injury after subarachnoid haemorrhage by modulating microglia polarization via the EPOR/JAK2-STAT3 pathway.
    Wei S; Luo C; Yu S; Gao J; Liu C; Wei Z; Zhang Z; Wei L; Yi B
    Exp Cell Res; 2017 Dec; 361(2):342-352. PubMed ID: 29102603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3.
    Guryanova OA; Wu Q; Cheng L; Lathia JD; Huang Z; Yang J; MacSwords J; Eyler CE; McLendon RE; Heddleston JM; Shou W; Hambardzumyan D; Lee J; Hjelmeland AB; Sloan AE; Bredel M; Stark GR; Rich JN; Bao S
    Cancer Cell; 2011 Apr; 19(4):498-511. PubMed ID: 21481791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase in renal erythropoietin receptors in diabetic rats is mainly mediated by hyperglycemia associated with the STAT3/GATA-1 signaling pathway.
    Kuo SC; Li Y; Cheng KC; Niu CS; Cheng JT; Niu HS
    Biomed Pharmacother; 2017 Dec; 96():1094-1102. PubMed ID: 29174036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT3, HIF-1alpha, EPO and EPOR - signaling proteins in human primary ductal breast cancers.
    Wincewicz A; Sulkowska M; Koda M; Leśniewicz T; Kanczuga-Koda L; Sulkowski S
    Folia Histochem Cytobiol; 2007; 45(2):81-6. PubMed ID: 17597020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus infection promotes the formation of glioma stem cells from glioblastoma cells through the TLR9/NEAT1/STAT3 pathway.
    Zang J; Zheng MH; Cao XL; Zhang YZ; Zhang YF; Gao XY; Cao Y; Shi M; Han H; Liang L
    Cell Commun Signal; 2020 Aug; 18(1):135. PubMed ID: 32843056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro.
    Våtsveen TK; Sponaas AM; Tian E; Zhang Q; Misund K; Sundan A; Børset M; Waage A; Brede G
    J Hematol Oncol; 2016 Aug; 9(1):75. PubMed ID: 27581518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistance.
    Shi Y; Guryanova OA; Zhou W; Liu C; Huang Z; Fang X; Wang X; Chen C; Wu Q; He Z; Wang W; Zhang W; Jiang T; Liu Q; Chen Y; Wang W; Wu J; Kim L; Gimple RC; Feng H; Kung HF; Yu JS; Rich JN; Ping YF; Bian XW; Bao S
    Sci Transl Med; 2018 May; 10(443):. PubMed ID: 29848664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma.
    Jeong HY; Kim HJ; Kim CE; Lee S; Choi MC; Kim SH
    Int J Neurosci; 2021 Jan; 131(1):7-14. PubMed ID: 32075484
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesis.
    Rainville N; Jachimowicz E; Wojchowski DM
    Expert Opin Ther Targets; 2016; 20(3):287-301. PubMed ID: 26419263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.